Paritaprevir/ritonavir-ombitasvir and dasabuvir, the 3D regimen for the treatment of chronic hepatitis C virus infection: a concise review

The treatment for chronic hepatitis C has been revolutionized with the development of direct-acting antiviral agents. Several regimens have been approved and are currently used in clinical practice, treating a wide range of patient populations infected with hepatitis C. The interferon-free combinati...

Descripción completa

Detalles Bibliográficos
Autor principal: Hussaini, Trana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876802/
https://www.ncbi.nlm.nih.gov/pubmed/27274322
http://dx.doi.org/10.2147/HMER.S72429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876802/
https://www.ncbi.nlm.nih.gov/pubmed/27274322
http://dx.doi.org/10.2147/HMER.S72429

Ejemplares similares